Effect of different drug-eluting stents on long-term clinical outcomes in patients with coronary artery disease based on differ-ent SYNTAX score
Objective To investigate the effect of biodegradable polymer drug-eluting stent(BP-DES)or durable polymer drug-eluting stent(DP-DES)on long-term clinical prognosis in patients with coronary artery disease based on different SYNTAX score.Methods 2 737 patients with BP-DES or DP-DES implanted in the I-LOVE-IT 2 study were selected as the study subjects.According to SYNTAX score,patients were divided into group A(SYNTAX score<7.0,n=774),group B(7.0≤SYNTAX score<13.5,n=1 046),and group C(SYNTAX score≥13.5,n=917).The primary endpoint event of this study was 4-year target lesion failure(TLF),which included the combined endpoint of cardiac death,target vessels myocardial infarction(TVMI),and ischemia-driven tar-get lesion revascularization.The secondary endpoints were all components of TLF and all-cause death.The clinical data,interventional data and endpoint events of the 3 groups were recorded and compared.Results There were significant differences in the proportion of hypertension,hyperlipidemia,previous myocardial infarction,previous percutaneous coronary intervention and creatinine clearance a-mong 3 groups(P<0.05).There were statistically significant differences in the number of stents,total length of stents and location of target vessels among 3 groups(P<0.05).There were significant differences in the incidence of TLF and TVMI among 3 groups(P<0.05).With the increase of SYNTAX score,the risk of TLF and TVMI in BP-DES and DP-DES patients increased.With the increase of SYNTAX score,the risk of TVMI in patients with BP-DES implantation was continuously lower than that in patients with DP-DES implantation,and there was no significant difference in the risk of TLF after implantation of the two stents.Conclusion With the in-crease of SYNTAX score,the risk of TLF and TVMI in patients with BP-DES and DP-DES increases,while the risk of TVMI in patients with BP-DES is continuously lower than that in patients with DP-DES.